Hospital Pharmacy Europe

JULY 14, 2025

Healthcare professionals have been urged to be alert for a small increased risk of Guillain-Barré syndrome following respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older. million doses of Abrysvo have been given as part of the older adult RSV vaccination programme. Paralysis can occur in some severe cases.

Vaccines

Drug Topics

JULY 29, 2025

The updated COVID-19 mRNA vaccine that contained the Omicron JN.1 Investigators analyzed 29 AEs of special interest for COVID-19 vaccinations. 1 The 2024-2025 updated COVID-19 vaccine containing the Omicron JN.1 1 booster vaccination. . 1 booster vaccination. years, were included. for myocarditis.

Vaccines

Drug Topics

JULY 18, 2025

The FDA has approved a prefilled syringe format of the recombinant zoster vaccine Shingrix for the prevention of shingles, GSK said in a release. 1 The company said approval of the new presentation was based on data that showed comparability between the new and existing version of the vaccine.

Vaccines

Pharmaceutical Technology

JUNE 20, 2025

June 20, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The MoU was signed at the BIO International Convention 2025 in Boston, US. The MoU was signed at the BIO International Convention 2025 in Boston, in the US state of Massachusetts. Credit: Department of Health Abu Dhabi.

Vaccines

Drug Topics

JUNE 23, 2025

Experts Debate Diabetes Care in Community Pharmacy vs Health Systems Despite evidence of improved diabetes outcomes, all pharmacy settings are capable of having a significant impact on diabetes care, according to a presentation at the American Pharmacists Association (APhA) 2025 Annual Meeting and Exposition.

Community Pharmacies

Pharmacy Times

JULY 22, 2025

RSV vaccines are recommended for older adults and those with specific health conditions, with options like Arexvy, mResvia, and Abrysvo available. RSV vaccines are recommended for older adults and those with specific health conditions, with options like Arexvy, mResvia, and Abrysvo available.

Vaccines

Pharmacy Times

JULY 16, 2025

The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, showcased significant advances across a range of malignancies, with novel agents, biomarker-driven strategies, and long-term outcomes data offering new insights into cancer treatment with implications for pharmacy practice.

HIV Treatment and Prevention Agents

Drug Topics

JUNE 27, 2025

In a vote of 5 to 1 on Thursday, members of the Advisory Committee on Immunization Practices (ACIP) voted to recommend against influenza vaccine containing the preservative thimerosal. The recommendations include all US adults as well as recommending pregnant women also receive a thimerosal-free vaccine for influenza.

Vaccines

Pharmacy Times

JUNE 24, 2025

Soefje, PharmD, MBA, BCOP, FCCP, FHOPA Scott Soefje, PharmD, MBA, BCOP, shares insights about the evolving role of pharmacists at the 2025 OPC meeting. Pharmacy Times : Can you share an overview of what you discussed at OPC 2025? Author(s): Alexandra Gerlach, Associate Editor , Scott A.

Compounding Pharmacies

Pharmacy Times

JULY 22, 2025

Finerenone and the Future of Diabetes-Related Kidney Care Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Subscribe Now!

Compounding Pharmacies

Drug Topics

AUGUST 8, 2025

1 READ MORE: Infections for Measles, Bird Flu, and Pertussis Increase in 2025 In China, where AMR is also on the rise, their systems for facilitating ASPs are complex and create difficulty for pharmacists and other providers to provide care. 2025 Jul 28;18:3735-3744. Accessed August 8, 2025. February 4, 2025.

Specialty Pharmacies

Drug Topics

JULY 17, 2025

1 “Eligible outcomes included changes in health-related quality of life, medication adherence, hospitalization rates, inhalation techniques, or disease-related knowledge." " Finally, pharmacist-led interventions were all conducted in community pharmacies, outpatient clinics, or hospital settings. 2025; [link] 2.

Specialty Pharmacies

Drug Topics

JUNE 19, 2025

Image Credit: WindyNight - stock.adobe.com "Our findings showed that adolescents who received this combination therapy were able to improve many symptoms typically associated with insulin-managed type one diabetes,” Farid Mahmud, MD, FRCPC, physician at The Hospital for Sick Children, said in a news release. June 17, 2025.

Compounding

Pharmacy Times

AUGUST 11, 2025

Transitions of care, or the movement of patients between health care settings or providers, impose a significant cost on the health care system due to frequent adverse events and hospital readmissions. 2 Although various programs aim to mitigate these risks, pharmacist-driven initiatives have proven particularly effective.

Hospitals

Pharmacy Times

AUGUST 5, 2025

Building trust and relationships with community partners is essential for effective vaccine advocacy and outreach. Offering education, mobile clinics, and convenient access to vaccines can address barriers and improve vaccination rates. Yet their potential as vaccine advocates often remains untapped.

Vaccines

Pharmacy Times

AUGUST 1, 2025

Accessed July 23, 2025. January 14, 2025. Accessed July 23, 2025. Accessed July 23, 2025. link] To Prohibit a Pharmacy Benefits Manager from Obtaining Certain Pharmacy Permits (AK HB1150); 2025. link] To Prohibit a Pharmacy Benefits Manager from Obtaining Certain Pharmacy Permits (AK HB1150); 2025.

Specialty Pharmacies

Pharmacy Times

JULY 14, 2025

McKesson ideaShare 2025 brought thousands of independent pharmacists, pharmacy owners, technicians, and industry leaders together in Nashville, Tennessee, shining a spotlight on innovation and advocacy in community pharmacy. Topics included innovative clinical services , vaccine access , and the interaction of pharmacology and nutrition.

Independent Pharmacies

Pharmacy Times

JULY 2, 2025

The injection's room-temperature stability and compatibility with automated dispensing cabinets facilitate integration into hospital workflows. The study authors noted that sepsis is also a leading cause of death and hospitalization that often requires antibiotic administration.

FDA

Pharmacy Times

JUNE 20, 2025

Pharmacy Times : Can you share your experience at OPC 2025 and the significance of these meetings for pharmacists? Related Videos Related Content Advertisement June 20th 2025 Unicorns Don’t Exist: Rethinking the Generalist Model in Oncology Pharmacy Kelley D. Sessions : Oncology Pharmacists Connect—this is the third year, right?

Compounding Pharmacies

Pharmacy Times

JULY 28, 2025

Grillo, MBA, RPh Key Takeaways Vaccination has saved millions of lives, yet vaccine hesitancy remains a significant global health threat, fueled by misinformation and systemic barriers. SHOW MORE Many factors contribute to vaccine skepticism, including trust, convenience, and fear. million premature deaths.

Vaccines

Pharmacy Times

JUNE 24, 2025

In an interview with Pharmacy Times® , Gabe Hinojosa, PharmD, BCOP, clinical pharmacy specialist oncology/hematology at UT Southwestern, discussed the evolving treatment landscape for multiple myeloma (MM) and presented data from the 2025 American Society of Clinical Oncology Annual Meeting (ASCO).

Compounding Pharmacies

Pharmacy Times

JULY 12, 2025

1 Howard’s team built their telehealth service in collaboration with hospitals and health systems, especially to tackle the issue of hospital readmissions for Medicare and Medicaid patients—each of which can cost hospitals thousands of dollars.

Independent Pharmacies

Pharmacy Times

AUGUST 7, 2025

Published 2025. Accessed August 1, 2025. Published July 31, 2025. Accessed August 1, 2025. FDA Requires Major Changes to Opioid Pain Medication Labeling to Emphasize Risks. Food and Drug Administration. FDA Emphasizes Opioid Risks in New Labeling Requirement. Dowell D, Ragan K, Jones C, Baldwin G, Chou R.

Labelling

Pharmacy Times

JULY 22, 2025

2 In April 2025, the FDA announced its plan to phase out the animal testing requirements and require new approach methodologies (NAMs) in early research to streamline which treatments will be safe and effective in humans, reduce drug development costs and timelines, and reduce testing in animals. Accessed June 19, 2025. April 10, 2025.

FDA

Pharmacy Times

JULY 22, 2025

Furthermore, delays in medication access can exacerbate chronic conditions, such as diabetes, hypertension, and asthma, leading to increased hospitalization rates. These deserts reduce access to critical health care services, such as vaccinations, health screenings, and point-of-care testing.

Mail-Order Pharmacies

Pharmacy Times

JULY 26, 2025

Accessed June 4, 2025. Accessed June 4, 2025. Updated February 15, 2025. Accessed June 4, 2025. Accessed June 4, 2025. Accessed June 4, 2025. Accessed June 4, 2025. Accessed June 4, 2025. Accessed June 4, 2025. REFERENCES Rivaroxaban. MedlinePlus. Updated April 15, 2023. link] Edoxaban.

Compounding Pharmacies

Pharmacy Times

AUGUST 8, 2025

In July 2025, Scientific Reports published study results suggesting that the combination of metformin and a glucagon-like peptide-1 (GLP-1) receptor agonist is more effective than other metformin combinations in protecting kidney function. Novo Nordisk; January 2025. Accessed August 8, 2025. Diabetes Obes Metab. doi:10.1111/dom.12128

HIV Treatment and Prevention Agents

Pharmacy Times

JUNE 27, 2025

On January 16, 2025, the FDA approved acalabrutinib (Calquence; AstraZeneca) in combination with bendamustine and rituximab for the treatment of adult patients with previously untreated mantle cell lymphoma (MCL) who are ineligible for autologous hematopoietic stem cell transplantation (HSCT).

FDA

Pharmacy Times

JUNE 9, 2025

These conclusions were presented as part of an abstract from the open-label, phase 3 CheckMate 816 trial (NCT02998528) at the 2025 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois, and subsequently published in the Journal of Clinical Oncology. J Clin Oncol. 2025;43(17). doi:10.1200/JCO.2025.43.17_suppl.LBA800.

Chemotherapy

Pharmacy Times

AUGUST 8, 2025

August 8, 2025. Accessed August 8, 2025. Updated July 28, 2025. Accessed August 8, 2025. May 30, 2025. Accessed August 8, 2025. The FDA's accelerated approval of zongertinib marks a significant advancement for patients with HER2-mutated NSCLC, offering a new treatment option. Pharmacy Times.

FDA

Pharmacy Times

JULY 21, 2025

Fournier, BSc Key Takeaways The 2024-2025 influenza season saw unprecedented severity, with high hospitalization and outpatient visit rates due to a vaccine mismatch and dominant H1N1 and H3N2 strains. 1 The US also reported the highest rates of hospitalizations and outpatient visits for flulike illnesses in 15 years.

Vaccines

Pharmacy Times

JULY 25, 2025

John’s University – College of Pharmacy and Health Sciences and practices as an infectious diseases pharmacist at NYC Health + Hospitals/Elmhurst in Elmhurst, New York. Accessed March 2, 2025. Accessed March 5, 2025. Accessed March 5, 2025. Clinical and Laboratory Standards Institute; 2025. Cephalexin. Lexi-Drugs.

HIV Treatment and Prevention Agents

Pharmacy Times

JUNE 9, 2025

A retrospective study presented at the American Society of Health-System Pharmacists 2025 Pharmacy Futures meeting has revealed significant variability in asthma treatment regimens following initial diagnosis, with many patients not receiving care aligned with the Global Initiative for Asthma (GINA) recommendations.

Compounding Pharmacies

Pharmacy Times

JULY 21, 2025

Accessed June 17, 2025. Updated February 2025. Accessed June 17, 2025. Related Videos Related Content Advertisement July 21st 2025 Under the Weather: Unpacking the Impact of the 2024-2025 Influenza Season Tori L. Health Sci Rep. 2025;8(4):e70747. doi:10.1002/hsr2.70747 Continuous glucose monitors. link] Miller EM.

Compounding Pharmacies

Pharmacy Times

JUNE 20, 2025

American Pharmaceutical Association; 2025. Accessed April 28, 2025. Accessed April 28, 2025. Terrie, BSPharm, RPh Key Takeaways Dysmenorrhea affects 50% to 90% of females, causing absenteeism and reduced quality of life, with primary and secondary types identified. Dysmenorrhea and endometriosis in the adolescent. December 2018.

Compounding Pharmacies

Pharmacy Times

JUNE 18, 2025

Accessed May 5, 2025. Accessed May 5, 2025. Impact of a combined pharmacist and social worker program to reduce hospital readmissions. Wick, MBA, RPh, FASCP Key Takeaways Pharmacists can address SDOH by providing patient-centered care, promoting immunizations, and offering point-of-care testing to improve health outcomes.

Immunization

Pharmacy Times

JUNE 11, 2025

The medical team, in collaboration with pharmacists, opted to use rilonacept and worked to expedite its delivery to the patient upon hospital discharge. What we did was we admitted him to the hospital. In an interview with Pharmacy Times ®, Allan L.

Specialty Pharmacies